Owing to the relatively small size of 227 amino acid residues for mature GrB, its broad substrate specificity, and its ability to bypass common apoptosis resistance mechanisms in tumor cells, GrB has been employed as an effector molecule for the generation of recombinant cell death-inducing fusion proteins [9], [10]. This evidence concerns the gene GZMB and neoplasm.